Bone Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Bone Cancer, including details on symptoms, types, treatment.

Volume 2 (2005), Issue 12 (December)

1. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
   Clin Cancer Res, 11(23): 8250-7. [Abstract] [Full-text]
2. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
   Cancer Res, 65(23): 11001-9. [Abstract] [Full-text]
3. Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity.
   Cancer Res, 65(23): 10921-9. [Abstract] [Full-text]
4. Acetabular development after bipolar hemiarthroplasty for osteosarcoma in children.
   J Bone Joint Surg Br, 87(12): 1658-62. [Abstract] [Full-text]
5. Surgical treatment of skeletal metastatic lesions of the proximal femur: endoprosthesis or reconstruction nail?
   J Bone Joint Surg Br, 87(12): 1653-7. [Abstract] [Full-text]
6. Rethinking orbital imaging establishing guidelines for interpreting orbital imaging studies and evaluating their predictive value in patients with orbital tumors.
   Ophthalmology, 112(12): 2196-207. [Abstract] [Full-text]
7. Giant cell tumors of the bone: molecular profiling and expression analysis of Ephrin A1 receptor, Claudin 7, CD52, FGFR3 and AMFR.
   Pathol Res Pract, 201(10): 649-63. [Abstract] [Full-text]
8. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy.
   Eur J Cancer, 41(18): 2836-45. [Abstract] [Full-text]
9. Periosteal osteosarcoma--a European review of outcome.
   Eur J Cancer, 41(18): 2806-11. [Abstract] [Full-text]
10. Differentiating imaging findings in primary and secondary tumors of the jugular foramen.
    Neurosurg Rev, 29(1): 1-11; discussion 12-13. [Abstract] [Full-text]
11. Pre- and post-chemotherapy alkaline phosphatase levels as prognostic indicators in adults with localised osteosarcoma.
    Eur J Cancer, 41(18): 2846-52. [Abstract] [Full-text]
12. Meningiomas of the jugular foramen.
    Neurosurg Rev, 29(1): 55-60. [Abstract] [Full-text]
13. HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition.
    Blood, 106(13): 4294-302. [Abstract] [Full-text]
14. Occupational factors and risk of adult bone sarcomas: a multicentric case-control study in Europe.
    Int J Cancer, 118(3): 721-7. [Abstract] [Full-text]
15. Comprehensive analysis of the p53 status in mucosal and cutaneous melanomas.
    Int J Cancer, 118(3): 577-82. [Abstract] [Full-text]
16. Rationale for individualized therapy in Sinonasal Teratocarcinosarcoma (SNTC): case report.
    Onkologie, 28(12): 653-6. [Abstract] [Full-text]
17. Present status and perspectives in the treatment of hormone-refractory prostate cancer.
    Oncology, 69(4): 273-82. [Abstract] [Full-text]
18. Analgesic effects of capsazepine and resiniferatoxin on bone cancer pain in mice.
    Neurosci Lett, 393(1): 70-3. [Abstract] [Full-text]
19. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
    BJU Int, 97(1): 51-5. [Abstract] [Full-text]
20. Autocrine motility factor/glucose-6-phosphate isomerase is a possible predictor of metastasis in bone and soft tissue tumours.
    J Pathol, 208(1): 44-53. [Abstract] [Full-text]
21. TGF-beta1 drives partial myofibroblastic differentiation in chondromyxoid fibroma of bone.
    J Pathol, 208(1): 26-34. [Abstract] [Full-text]
22. Technetium tc 99m-labeled red blood cells in the preoperative diagnosis of cavernous hemangioma and other vascular orbital tumors.
    Arch Ophthalmol, 123(12): 1678-83. [Abstract] [Full-text]
23. Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activity.
    Clin Cancer Res, 11(24): 8822-8. [Abstract] [Full-text]
24. Immunohistochemical and genetic analysis of Chinese nasal natural killer/T-cell lymphomas.
    Hum Pathol, 37(1): 54-60. [Abstract] [Full-text]
25. Long-term prevention of skeletal complications by pamidronate in a patient with bone metastasis from endometrial carcinoma: a case report.
    Gynecol Oncol, 100(1): 195-7. [Abstract] [Full-text]
26. Percutaneous vertebroplasty for spinal metastases: complications.
    Radiology, 238(1): 354-62. [Abstract] [Full-text]
27. Added value of SPECT/CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and nonfused scintigraphy and CT.
    Radiology, 238(1): 264-71. [Abstract] [Full-text]
28. Interleukin-12 up-regulates Fas expression in human osteosarcoma and Ewing's sarcoma cells by enhancing its promoter activity.
    Mol Cancer Res, 3(12): 685-91. [Abstract] [Full-text]
29. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma.
    J Clin Oncol, 24(1): 181-9. [Abstract] [Full-text]
30. Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group.
    J Clin Oncol, 24(1): 152-9. [Abstract] [Full-text]

© 2004-2008 Bone Cancer Research Today. All Rights Reserved.